ATS 2018 International Conference - Mobile

Characteristics and Outcomes of COPD Patients with Blood Eosinophils ≥150 Cells/µL Who Continue to Exacerbate Whilst Treated with Multiple Inhaler Triple Therapy [Board No. P1369]

Location: Board no. P1369

Session Type: Thematic Poster Session

Monday

May

21

11:15 AM

1:00 PM

Speaker(s)/Author(s)

Frank C. Albers

MD, PhD
GlaxoSmithKline;GSK

Dmitry Galkin

MD
GSK

Sarah Landis

Ph D
GSK

Wilhelmine H. Meeraus

PhD
GSK

Hana Müllerová

PhD, PharmDr
GSK

View Abstract

Characteristics and Outcomes of COPD Patients with Blood Eosinophils ≥150 Cells/µL Who Continue to Exacerbate Whilst Treated with Multiple Inhaler Triple Therapy

Parent Sessions

B36 - BIOMARKERS IN COPD
05-21-2018 9:15 AM - 4:15 PM